{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:56:04Z","timestamp":1760122564993},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.yexcr.2016.07.020","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T14:07:46Z","timestamp":1469023666000},"page":"115-122","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Silencing cardiomyocyte TLR4 reduces injury following hypoxia"],"prefix":"10.1016","volume":"348","author":[{"given":"Orna","family":"Avlas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smadar","family":"Srara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Shainberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Aravot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Hochhauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2016.07.020_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/08830185.2012.706761","article-title":"Toll-like receptor signaling pathways in cardiovascular diseases: challenges and opportunities","volume":"31","author":"Moghimpour Bijani","year":"2012","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaci.2006.02.023","article-title":"Toll-like receptor function and signaling","volume":"117","author":"Kaisho","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.062","article-title":"Innate immunity and cardiomyocytes in ischemic heart disease","volume":"100","author":"Lin","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.yexcr.2016.07.020_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fphys.2014.00496","article-title":"Ischemia\/reperfusion activates myocardial innate immune response: the key role of the toll-like receptor","volume":"5","author":"Vilahur","year":"2014","journal-title":"Front Physiol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib5","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1089\/ars.2010.3728","article-title":"Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility","volume":"15","author":"Avlas","year":"2010","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.yexcr.2016.07.020_bib6","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.yjmcc.2010.02.020","article-title":"Cardiomyocyte toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia","volume":"48","author":"Fallach","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib7","doi-asserted-by":"crossref","first-page":"e0120175","DOI":"10.1371\/journal.pone.0120175","article-title":"TLR4 expression is associated with left ventricular dysfunction in patients undergoing coronary artery bypass surgery","volume":"10","author":"Avlas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2016.07.020_bib8","doi-asserted-by":"crossref","first-page":"H848","DOI":"10.1152\/ajpheart.01007.2010","article-title":"Glucan phosphate attenuates myocardial HMGB1 translocation in severe sepsis through inhibiting NF-kappaB activation","volume":"301","author":"Ha","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-012-0267-3","article-title":"Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway","volume":"107","author":"Yao","year":"2012","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib10","doi-asserted-by":"crossref","first-page":"H1490","DOI":"10.1152\/ajpheart.00910.2007","article-title":"Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes","volume":"294","author":"Tzeng","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/pr.107.06002","article-title":"Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning","volume":"59","author":"Ferdinandy","year":"2007","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.yexcr.2016.07.020_bib12","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1053\/j.jvca.2008.03.005","article-title":"Postconditioning by volatile anesthetics: salvaging ischemic myocardium at reperfusion by activation of prosurvival signaling","volume":"22","author":"Pagel","year":"2008","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.yexcr.2016.07.020_bib13","doi-asserted-by":"crossref","first-page":"e76652","DOI":"10.1371\/journal.pone.0076652","article-title":"Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2016.07.020_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cvr\/cvp274","article-title":"Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway","volume":"84","author":"Lacerda","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2016.07.020_bib15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nri2402","article-title":"Harmful molecular mechanisms in sepsis","volume":"8","author":"Rittirsch","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yexcr.2014.07.013","article-title":"Sirtuin 6 protects the heart from hypoxic damage","volume":"330","author":"Maksin-Matveev","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2016.07.020_bib17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2741\/1304","article-title":"NF-kappaB action in sepsis: the innate immune system and the heart","volume":"9","author":"Brown","year":"2004","journal-title":"Front Biosci."},{"key":"10.1016\/j.yexcr.2016.07.020_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.RES.0000138303.76488.fe","article-title":"Postconditioning: a form of \u201cmodified reperfusion\u201d protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway","volume":"95","author":"Tsang","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2016.07.020_bib19","doi-asserted-by":"crossref","first-page":"H971","DOI":"10.1152\/ajpheart.00374.2004","article-title":"Ischemic preconditioning protects by activating prosurvival kinases at reperfusion","volume":"288","author":"Hausenloy","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2016.07.020_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardiores.2006.09.011","article-title":"Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response","volume":"72","author":"Boyd","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2016.07.020_bib22","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/01.CIR.100.23.2373","article-title":"Adenoviral gene transfer of activated phosphatidylinositol 3\u2019-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro","volume":"100","author":"Matsui","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2016.07.020_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","article-title":"Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart","volume":"101","author":"Fujio","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2016.07.020_bib24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cardiores.2003.09.007","article-title":"Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection","volume":"61","author":"Li","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2016.07.020_bib25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/cvr\/cvn037","article-title":"Lipopolysaccharide-induced myocardial protection against ischaemia\/reperfusion injury is mediated through a PI3K\/Akt-dependent mechanism","volume":"78","author":"Ha","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexcr.2016.07.020_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10557-006-0583-7","article-title":"The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia\/reperfusion injury: apoptosis meets autophagy","volume":"20","author":"Hamacher-Brady","year":"2006","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.yexcr.2016.07.020_bib27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.gene.2013.05.041","article-title":"The HMGB1-TLR4 axis contributes to myocardial ischemia\/reperfusion injury via regulation of cardiomyocyte apoptosis","volume":"527","author":"Ding","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2016.07.020_bib28","doi-asserted-by":"crossref","first-page":"32124","DOI":"10.1074\/jbc.M203298200","article-title":"The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells","volume":"277","author":"Guha","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.yexcr.2016.07.020_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib30","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1089\/ars.2010.3723","article-title":"Toll-like receptors: new players in myocardial ischemia\/reperfusion injury","volume":"15","author":"Ha","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.yexcr.2016.07.020_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jtcvs.2003.11.036","article-title":"Toll-like receptor 4 mediates ischemia\/reperfusion injury of the heart","volume":"128","author":"Chong","year":"2004","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yexcr.2016.07.020_bib32","article-title":"A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy\u2019 against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury","volume":"96","author":"Sawa","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2016.07.020_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI6709","article-title":"Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium","volume":"104","author":"Frantz","year":"1999","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.yexcr.2016.07.020_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2007.08.014","article-title":"Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia\/reperfusion","volume":"190","author":"Hua","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.yexcr.2016.07.020_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1124\/pr.109.001073","article-title":"Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer","volume":"61","author":"O\u2019Neill","year":"2009","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.yexcr.2016.07.020_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-10-23","article-title":"Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia","volume":"10","author":"Yao","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.yexcr.2016.07.020_bib37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.athoracsur.2014.12.062","article-title":"Role of toll-like receptor-4 in lung ischemia-reperfusion injury","volume":"99","author":"Merry","year":"2015","journal-title":"Ann. Thorac. Surg."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482716302075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482716302075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T10:56:39Z","timestamp":1536576999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482716302075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0014482716302075"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.07.020","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silencing cardiomyocyte TLR4 reduces injury following hypoxia","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2016.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}